ACTIVE

DECON

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

196,6 k €

+24.8% YoY

Gross margin

412,3 k €

+12.3% YoY

Equity

1,6 M €

-17.1% YoY

Workforce

2,0 ETP

-20.0% YoY

What does DECON do?

DECON is a Public limited company incorporated in 1987. Its registered office is in Maasmechelen. It employs on average 2,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0430.414.536

Incorporation

03/02/1987

Legal form

Public limited company

Registered office

Vrijthof(E) 7
3630 Maasmechelen · FlandreSee on map

Contributed capital

61 973,38 €

Latest accounts

31/12/2025

Average workforce

2,0 ETP

Joint committees (1)

Contacts

2 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	412,3 k €	+12.3%	367,3 k €	+15.4%	318,4 k €	-6.4%	340,3 k €	-12.7%	389,8 k €	+55.0%	251,6 k €	+9.8%	229,2 k €	+47.9%	155 k €	-45.4%	283,7 k €	-7.4%	306,4 k €	+6.0%	289,1 k €	-5.1%	304,7 k €	+9.1%	279,3 k €	+1.2%	276 k €	-8.7%	302,3 k €	+10.4%	273,8 k €	+6.2%	257,7 k €	+7.3%	240,1 k €	+0.4%	239,1 k €	+5.1%	227,5 k €
EBITDA	322,5 k €	+30.7%	246,8 k €	+19.4%	206,7 k €	+13.8%	181,6 k €	-32.8%	270,3 k €	+113%	126,8 k €	+108%	60,9 k €	+413%	-19,5 k €	-116%	120,5 k €	-2.9%	124,1 k €	+32.9%	93,4 k €	-26.1%	126,4 k €	+13.5%	111,3 k €	+33.0%	83,7 k €	-26.7%	114,2 k €	+25.0%	91,3 k €	+11.5%	82 k €	+24.0%	66,1 k €	-30.2%	94,7 k €	+52.2%	62,2 k €
Operating result	317,1 k €	+31.3%	241,6 k €	+20.2%	201 k €	+14.6%	175,4 k €	-34.3%	266,9 k €	+116%	123,6 k €	+123%	55,4 k €	+330%	-24,1 k €	-121%	115,6 k €	+3.9%	111,3 k €	+38.0%	80,6 k €	-29.6%	114,6 k €	+20.9%	94,7 k €	+38.4%	68,5 k €	-35.9%	106,8 k €	+27.2%	83,9 k €	+17.3%	71,5 k €	+22.9%	58,2 k €	-32.8%	86,6 k €	+59.7%	54,3 k €
Net result	196,6 k €	+24.8%	157,5 k €	+22.6%	128,5 k €	+7.4%	119,6 k €	-40.4%	200,7 k €	+131%	86,7 k €	+35.0%	64,2 k €	+861%	-8,4 k €	-111%	79,9 k €	-12.0%	90,9 k €	+55.7%	58,4 k €	-46.9%	109,9 k €	+0.7%	109,2 k €	+13.1%	96,5 k €	-19.1%	119,4 k €	+13.0%	105,7 k €	+9.5%	96,5 k €	+13.9%	84,7 k €	-16.5%	101,5 k €	+35.3%	75 k €
Balance sheet
Equity	1,6 M €	-17.1%	1,9 M €	+9.1%	1,7 M €	+8.0%	1,6 M €	+8.1%	1,5 M €	+15.7%	1,3 M €	+7.3%	1,2 M €	+5.7%	1,1 M €	-31.1%	1,6 M €	+5.1%	1,6 M €	+6.2%	1,5 M €	+4.2%	1,4 M €	+8.5%	1,3 M €	-0.5%	1,3 M €	+8.0%	1,2 M €	+10.8%	1,1 M €	+10.5%	984,5 k €	+10.6%	890,4 k €	+10.2%	808,2 k €	+14.0%	709,1 k €
Total assets	2,5 M €	+9.9%	2,3 M €	+8.8%	2,1 M €	+8.5%	1,9 M €	+7.2%	1,8 M €	+12.6%	1,6 M €	+3.9%	1,5 M €	+6.5%	1,4 M €	-21.6%	1,8 M €	+4.0%	1,8 M €	+6.4%	1,7 M €	+3.4%	1,6 M €	+4.7%	1,5 M €	+1.8%	1,5 M €	+9.1%	1,4 M €	+10.3%	1,2 M €	+7.3%	1,2 M €	+12.2%	1 M €	+1.3%	1 M €	+12.3%	909,1 k €
Cash	2 M €	+11.7%	1,8 M €	+4.1%	1,7 M €	+12.2%	1,5 M €	+6.8%	1,4 M €	+17.3%	1,2 M €	+9.7%	1,1 M €	+10.2%	991,2 k €	-6.7%	1,1 M €	+15.0%	924,2 k €	+5.9%	872,9 k €	-24.2%	1,2 M €	+7.4%	1,1 M €	+2.4%	1 M €	+5.0%	996,6 k €	+10.5%	902 k €	+9.3%	825,5 k €	+21.7%	678,3 k €	+8.3%	626,6 k €	+24.6%	503 k €
Debts	896,5 k €	+144%	368 k €	+11.5%	330 k €	+6.9%	308,8 k €	+5.2%	293,6 k €	-1.3%	297,4 k €	-10.4%	331,9 k €	+8.6%	305,6 k €	+61.3%	189,5 k €	-5.6%	200,7 k €	+7.0%	187,5 k €	-0.8%	189 k €	-16.4%	226 k €	+17.3%	192,7 k €	+17.0%	164,7 k €	+8.0%	152,5 k €	-12.1%	173,4 k €	+24.8%	138,9 k €	-33.5%	209 k €	+6.4%	196,5 k €
Other
Workforce	2,0 ETP	-20.0%	2,5 ETP	-3.8%	2,6 ETP	-18.8%	3,2 ETP	+10.3%	2,9 ETP	-21.6%	3,7 ETP	0.0%	3,7 ETP	-7.5%	4,0 ETP	-7.0%	4,3 ETP	-10.4%	4,8 ETP	0.0%	4,8 ETP	-11.1%	5,4 ETP	+25.6%	4,3 ETP	-10.4%	4,8 ETP	-18.6%	5,9 ETP	+11.3%	5,3 ETP	0.0%	5,3 ETP	-1.9%	5,4 ETP	0.0%	5,4 ETP	-1.8%	5,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 10 ended

Active mandates

Ludo Conings

Managing director

Active

Marie-Rose Devlies

Director

Active

PharmaSi

Director · 0687.947.061

Represented by Conings SIGRID

Active

Ended mandates

JEAN CONINGS

Administrator - manager · since 16 janvier 2018 · until 16 janvier 2024

Ended

LUDO CONINGS

Managing director · since 16 janvier 2018 · until 16 janvier 2024

Ended

PharmaSi

Administrator - manager · since 16 janvier 2018 · until 16 janvier 2024 · 0687.947.061

Ended

JEAN CONINGS

Managing director · since 17 septembre 1996

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/08/2026	22/08/2025	16/07/2024	29/09/2023	29/07/2022	26/08/2021
General meeting	07/05/2026	02/05/2025	02/05/2024	04/05/2023	05/05/2022	06/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	07/05/2026	25/08/2026	Dutch	PDF
Abridged model	31/12/2024	02/05/2025	22/08/2025	Dutch	PDF
Abridged model	31/12/2023	02/05/2024	16/07/2024	Dutch	PDF
Abridged modelCorrection	31/12/2022	04/05/2023	29/09/2023	Dutch	PDF
Abridged model	31/12/2022	04/05/2023	28/07/2023	Dutch	PDF
Abridged model	31/12/2021	05/05/2022	29/07/2022	Dutch	PDF
Abridged model	31/12/2020	06/05/2021	26/08/2021	Dutch	PDF
Abridged model	31/12/2019	07/05/2020	30/07/2020	Dutch	PDF
Abridged model	31/12/2018	02/05/2019	09/08/2019	Dutch	PDF
Abridged model	31/12/2017	03/05/2018	26/07/2018	Dutch	PDF
Abridged model	31/12/2016	04/05/2017	02/08/2017	Dutch	PDF
Abridged model	31/12/2015	06/05/2016	01/08/2016	Dutch	PDF
Abridged model	31/12/2014	07/05/2015	12/08/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	25/07/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	13/08/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	14/08/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	16/08/2011	Dutch	PDF
Abridged model	31/12/2009	17/06/2010	12/07/2010	Dutch	PDF
Abridged model	31/12/2008	28/05/2009	19/06/2009	Dutch	PDF
Abridged model	31/12/2007	29/05/2008	27/06/2008	Dutch	PDF
Abridged model	31/12/2006	21/06/2007	13/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 10 ended

Active mandates

Ludo Conings

Managing director

Active

Marie-Rose Devlies

Director

Active

PharmaSi

Director · 0687.947.061

Represented by Conings SIGRID

Active

Ended mandates

JEAN CONINGS

Administrator - manager · since 16 janvier 2018 · until 16 janvier 2024

Ended

LUDO CONINGS

Managing director · since 16 janvier 2018 · until 16 janvier 2024

Ended

PharmaSi

Administrator - manager · since 16 janvier 2018 · until 16 janvier 2024 · 0687.947.061

Ended

JEAN CONINGS

Managing director · since 17 septembre 1996

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Capital / shares25/02/2025
KAPITAAL - AANDELEN
PDF
Other28/05/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates01/04/2021
DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/02/2018
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares30/01/2018
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates10/12/2014
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares08/01/2014
KAPITAAL - AANDELEN
PDF
Mandates26/09/2012
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025196,6 k €↑
2024
Annual accounts 2024157,5 k €↑
2023
Annual accounts 2023128,5 k €↑
2022
Annual accounts 2022119,6 k €↓
2021
Annual accounts 2021200,7 k €↑
2020
Annual accounts 202086,7 k €↑
2019
Annual accounts 201964,2 k €↑
2018
Annual accounts 2018-8,4 k €↓
2017
Annual accounts 201779,9 k €↓
2016
Annual accounts 201690,9 k €↑
2015
Annual accounts 201558,4 k €↓
2014
Annual accounts 2014109,9 k €↑
2013
Annual accounts 2013109,2 k €↑
2012
Annual accounts 201296,5 k €↓
2011
Annual accounts 2011119,4 k €↑
2010
Annual accounts 2010105,7 k €↑
2009
Annual accounts 200996,5 k €↑
2008
Annual accounts 200884,7 k €↓
2007
Annual accounts 2007101,5 k €↑
2006
Annual accounts 200675 k €
03/02/1987
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

DECON

Overview

What does DECON do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline